A phase 3 clinical trial has demonstrated that daraxonrasib significantly improved overall survival and progression-free ...

A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for ...

Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic ...

The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based on the ...

A shift in the way people think about and treat pancreatic cancer could be on the horizon based on positive results from the pivotal randomized Phase III RASolute 302 trial comparing daraxonrasib to ...

Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...

A glimmer of hope may be on the horizon for a ruthless cancer that former Sen. Ben Sasse (R-Neb.) once called a "definite death sentence." An experimental treatment from Revolution Medicines helped ...

Months after revealing his stage 4 cancer diagnosis, former U.S. Sen. Ben Sasse is speaking out about an experimental therapy that could extend his life. Sasse, a Republican who represented Nebraska ...

For today's 19 million cancer survivors, these findings add to the growing body of research that speaks to the power of ...